It's definitely not management's fault. We are a thinly traded stock on the red light district bulletin board. The price is easily pushed around by idiots who don't know what a cancer vaccine is. They blindly short any low float low price stock. Our management knows this. That is why they want to uplist in 2014.
News 
Market Data 
Discover 
AI
